GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Xintela AB (FRA:1XT) » Definitions » Cash Flow for Lease Financing

Xintela AB (FRA:1XT) Cash Flow for Lease Financing : €0.00 Mil (TTM As of Jun. 2024)


View and export this data going back to 2018. Start your Free Trial

What is Xintela AB Cash Flow for Lease Financing?

Xintela AB's Cash Flow for Lease Financing for the three months ended in Jun. 2024 was €0.00 Mil. Xintela AB's Cash Flow for Lease Financing for the trailing twelve months (TTM) ended in Jun. 2024 was €0.00 Mil.

Compared with last quarter (€0.00 Mil in Mar. 2024 ), Xintela AB's Cash Flow for Lease Financing remained the same in Jun. 2024 (€0.00 Mil).

Xintela AB Cash Flow for Lease Financing Historical Data

The historical data trend for Xintela AB's Cash Flow for Lease Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Xintela AB Cash Flow for Lease Financing Chart

Xintela AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cash Flow for Lease Financing
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Xintela AB Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Cash Flow for Lease Financing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Xintela AB Cash Flow for Lease Financing Calculation

Cash Flow for Lease Financing is change in cash flow resulting from increase or decrease in lease financing.


Cash Flow for Lease Financing for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Xintela AB Cash Flow for Lease Financing Related Terms

Thank you for viewing the detailed overview of Xintela AB's Cash Flow for Lease Financing provided by GuruFocus.com. Please click on the following links to see related term pages.

Xintela AB Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Xintela AB (FRA:1XT) » Definitions » Cash Flow for Lease Financing
Comparable Companies
XSAT:WNT XSAT:DEX NGM:GTAB B OSTO:ZICC OSTO:ANNX OSTO:SIMRIS B OSTO:LIPUM OSTO:ACE XSAT:CESSA XSAT:RESP OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
XINT:Sweden
Address
Medicon Village, Lund, SWE, 22381
Website
https://www.xintela.se
Xintela AB is a biomedical company that develops stem cell-based treatments with a focus on osteoarthritis and hard-to-heal leg wounds as well as, through the wholly-owned subsidiary Targinta, targeted antibody-based treatments for aggressive cancers such as triple-negative breast cancer and the brain tumor glioblastoma.

Xintela AB Headlines

No Headlines